SYNJ2BP and brucellosis: rOMP25 (IFA-CS) and rOMP25 (AH-CS) injections showed no enhancement to humoral responses compared with individual inclusion of IF and AH (Figure 2). The cell proliferative response indicated vaccination with OMP25 elicits a vigorous antigen-specific cell proliferative response that could be promoted after the immunization with CS and this would be vital for controlling Brucellosis.